High‐dose influenza vaccine reduces laboratoryconfirmed influenza by 24% more than standard‐dose influenza vaccine in elderly patients (SOR: B, single RCT). High‐dose vaccine is associated with a lower rate of probable influenza and hospital admission d...
A recent study reveals the QIV-HD vaccine significantly lowers hospitalization rates compared to the standard-dose vaccine (QIV-SD). A randomized DANFLU-1 clinical vaccine trial, as documented in Clinical Microbiology and Infection compared the QIV-HD with the QIV-SD. The vaccine...
Fluzone High-Dose Quadrivalent vaccine is for people 65 years of age and older. Vaccination with Fluzone High-Dose Quadrivalent vaccine may not protect all people who receive the vaccine. What are the side effects of Fluzone Highdose? The most common side effects of Fluzone High-Dose Quadriva...
Electron microscopy of influenza virus. Credit: CDC In the largest nursing home study to date on the effect of a high dose (HD) flu vaccine, researchers found that vaccines with four times the antigen of standard flu (SD) vaccines significantly reduced the risk of respiratory and all-cause h...
Results from a new study suggest that high-dose influenza vaccine is associated with lower risk for hospitalizations in kidney failure patients on dialysis. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephr
Because influenza vaccines are often less effective in older adults, the higher dose vaccines or adjuvanted vaccine is recommended in this population. For the 2024-25 influenza season, ACIP recommends that adults ≥65 years preferentially receive trivalent high-dose inactivated influenza vaccine (HD-...
We examined the safety and immunogenicity of high dose influenza vaccine (HD) compared to standard dose vaccine (SD) in participants with RA receiving stable TNFi.A randomized, double-blinded, Phase II study was conducted in adults with RA receiving TNFi, and healthy, gender and age-matched ...
Strategies employed to improve vaccine efficacy involve using structure-based design and nanoparticle display to optimize the antigenicity and immunogenicity of target antigens; increasing the antigen dose; using novel adjuvants; stimulating cellular immunity; and targeting other viral proteins, including ...
In 2024,Vaccinedoes not include H5N1 (Bird Flu), but is in production if case it is needed Influenza Vaccines in 2022 and 2023 U.S. were quadrivalent (contained B/Yamagata) High dose and augmentedVaccines Indicated for age >65 years old, to improve immune response toVaccineand reduceInfluenz...
High-dose influenza vaccine cost effective in high-risk adultsNo Abstract available for this article.doi:10.1007/s40274-017-4347-3NoneSpringer International PublishingPharmacoeconomics & Outcomes News